A Randomized, Open-Label, Two-Way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis - Related Studies

A Randomized, Open-Label, Two-Way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis

This study has been completed.

Study NCT00139893. Last updated on May 16, 2008. Information provided by UCB

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Diabetic Gastroparesis

2	Additional conditions recognized in this trial
		Gastroparesis

3	More general conditions related to this trial
		Digestive System Diseases
		Gastrointestinal Diseases
		Neurologic Manifestations
		Paralysis
		Signs and Symptoms
		Stomach Diseases

4	Interventions listed in this trial
		Reglan ODT

5	Additional drug interventions recognized in this trial
		Metoclopramide

6	More general drug interventions related to this trial
		Antiemetics
		Autonomic Agents
		Central Nervous System Agents
		Dopamine Agents
		Dopamine Antagonists
		Gastrointestinal Agents
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		UCB